Humabs Biomed
Trending Articles
Related Content
Research & Development
Humabs BioMed and UC Berkeley publish data for novel assay to detect Zika virus
Humabs BioMed SA, a leading Swiss antibody therapeutics company, and the University of California, Berkeley announced the publication of data with an antibody-based assay, developed by Humabs, to detect and differentiate Zika virus infections from other flaviviruses such as dengue in the leading peer-reviewed journal, <i>Proceedings of the National Academy of Sciences</i>